Plans for a Clinical Trial of Coversin in Patients With Thrombotic Microangiopathies Have Been Announced
<a href="https://pixabay.com/users/mohamed_hassan/">mohamed_hassan</a> / Pixabay

Plans for a Clinical Trial of Coversin in Patients With Thrombotic Microangiopathies Have Been Announced

A drug called Coversin is being investigated as a potential treatment for four orphan diseases: bullous pemphigoid (BP), atypical keratoconjunctivitis (AKC), thrombotic microangiopathies, and paroxysmal nocturnal hemoglobinuria (PNH). Recently, new…

Continue Reading
Close Menu